This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Calgary directory, so their courses and email address may be missing. Find their university profile.
Latest papers
Evaluation and Management of Hypertensive Disorders of Pregnancy.
Kidney360 · 2023
Latest funding
- $50,000
Sex, Gender, and Health: Catalyzing Change in an Evolving World
CIHR · 2025 · Nominated PI
- $707,625
Sex and estrogen-dependent cross-talk between macrophages and adipocyte progenitors during adipose remodelling in obesity.
CIHR · 2024 · Co-investigator
- $1,500,000
Prevention of Nephrotoxin-induced Acute Kidney Injury with Cilastatin (PONTIAC) Trial
CIHR · 2024 · Co-investigator
1 publications.
Evaluation and Management of Hypertensive Disorders of Pregnancy.
Bajpai D, Popa C, Verma P, Dumanski S, Shah S
Sex, Gender, and Health: Catalyzing Change in an Evolving World
Principal investigators: Dumanski, Sandi; WIlliams, Sacha
Keywords: Gender; Knowledge Mobilization; Sex; Transdisciplinary
Sex and estrogen-dependent cross-talk between macrophages and adipocyte progenitors during adipose remodelling in obesity.
Principal investigators: Thompson, Jennifer A
Keywords: Adipogenesis; Adipose Tissue; Estrogen; Macrophages; Menopause; Obesity; Sex; Stem Cells
Prevention of Nephrotoxin-induced Acute Kidney Injury with Cilastatin (PONTIAC) Trial
Principal investigators: James, Matthew T; Levin, Adeera; Pannu, Neesh I
Keywords: Cardiovascular Disease; Kidney Disease; Nephrotoxicity; Randomized Controlled Trial
EQUIP Re-CKD: EQUity In Predicting Re-hospitalization among people with Chronic Kidney Disease
Principal investigators: Elliott, Meghan; Pannu, Neesh I; Donald, Maoliosa (Mo); Harrison, Tyrone; Ravani, Pietro
Keywords: Health Equity; Kidney Disease; Multiple Methods; Participatory Research; Re-Hospitalization; Risk Prediction
Prevention of Nephrotoxin-induced Acute Kidney Injury with Cilastatin (PONTIAC) Trial
Principal investigators: James, Matthew T; Muruve, Daniel A; Pannu, Neesh I
Keywords: Cardiovascular Disease; Clinical Trial; Kidney Disease; Nephrotoxicity
Cardiovascular Health in Transgender Hormone-Therapy Research Priority Setting
Principal investigators: Rytz, Chantal
Keywords: Cardiovascular Health; Community Engagement; Estrogen; Gender-Affirming Hormone Therapy; Gender-Diverse; Non-Binary; Patient-Identified Priorities; Priority Setting; Testosterone; Transgender Health
Anti-Müllerian Hormone and Cardiovascular Risk in Males with Chronic Kidney Disease: Preliminary Findings From a Cross-Sectional Study
Principal investigators: Larsen, Nicole
Keywords: Anti-Müllerian Hormone (Amh)
Cafe Scientifique: The HeART of Women's Health- At The Intersection of Art and Science
Principal investigators: Dumanski, Sandi; Esler, Jacqui; Porter, Danaka M
Keywords: Art; Cardiovascular; Community Engagement; Knowledge Mobilization; Women
Anti-Müllerian hormone and cardiovascular risk in males with chronic kidney disease: A protocol.
Principal investigators: Larsen, Nicole
Keywords: Amh; Anti-Muellerian Hormone; Cardiovascular; Ckd
Gender-affirming estrogen therapy and kidney function in transgender women
Principal investigators: Ahmed, Sofia B
Keywords: Blood Pressure; Estrogen; Gender-Affirming Hormone Therapy; Kidney; Transgender Women
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.